Guidance: UK SMI V 58: SARS-CoV-2 serology
UK Standards for Microbiology Investigations V 58: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) serology
UK Standards for Microbiology Investigations V 58: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) serology
Weekly data from UK laboratories on the number of cases of notifiable bacteria and viruses.
Guidance on the management of staff, patients and residents who have been exposed to COVID-19.
Information for healthcare professionals on myocarditis and pericarditis following COVID-19 vaccination.
Information for healthcare professionals on blood clotting following COVID-19 vaccination.
Information for eligible adults on COVID-19 vaccination.
Data across all Event Research Programme (ERP) phases show cases observed in and around events were in line with, or below, community prevalence
Information for healthcare professionals on Guillain-Barré Syndrome (GBS) following COVID-19 vaccination.
Immunology services and teams should record information as described in these checklists.
Details of MRL laboratory services including malaria diagnosis.